Literature DB >> 11757635

Gelatinase expression in pulmonary arteries during experimental pulmonary hypertension.

E Frisdal1, V Gest, A Vieillard-Baron, M Levame, H Lepetit, S Eddahibi, C Lafuma, A Harf, S Adnot, M P Dortho.   

Abstract

Structural remodelling of pulmonary vessels is an important feature of pulmonary hypertension (PH), which reflects distal artery muscularization and matrix remodelling. The matrix metalloproteinases (MMPs) are involved in extracellular matrix turnover and hence, in smooth muscle cell migration and endothelial cell migration and proliferation. Among the MMPs, gelatinases (MMP-2 and MMP-9) can degrade basement membrane components and promote cell proliferation and migration. This study evaluated gelatinases in pulmonary vessels during progressive PH in two rat models: exposure to hypoxia or monocrotaline. Zymography of tissue homogenates revealed an association of progression of hypoxic PH with a time-dependent increase in gelatinase MMP-2 activity, specific to pulmonary vessels. Increased MMP-2 activity was also found 30 days postmonocrotaline. Reverse transcription polymerase chain reaction demonstrated upregulation of MMP-2 messenger ribonucleic acid. Immunolocalization showed MMP-2 throughout the pulmonary vasculature, from the trunk to the distal vessels, with strong staining of the intima, media and adventitia. MMP-2 was found in its active form and gelatinolytic activity was correlated to PH severity. Activity localization by in situ zymography corroborated with the immunolocalization findings. In conclusion, the authors demonstrated that matrix metalloproteinase-2 activity is increased in pulmonary vessels during progression of pulmonary hypertension, probably as a result of involvement in the matrix turnover associated with vascular remodelling during pulmonary hypertension.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11757635     DOI: 10.1183/09031936.01.00084601

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  29 in total

Review 1.  PPARgamma as a potential therapeutic target in pulmonary hypertension.

Authors:  Roy L Sutliff; Bum-Yong Kang; C Michael Hart
Journal:  Ther Adv Respir Dis       Date:  2010-06       Impact factor: 4.031

Review 2.  PDGF signaling in pulmonary arterial hypertension.

Authors:  Robyn J Barst
Journal:  J Clin Invest       Date:  2005-10       Impact factor: 14.808

3.  Role of MMP-2 in inhibiting Na+ dependent Ca2+ uptake by H2O2 in microsomes isolated from pulmonary smooth muscle.

Authors:  Amritlal Mandal; Tapati Chakraborti; Rajdeep Choudhury; Biswarup Ghosh; Amar Nath Ghosh; Sudip Das; Sajal Chakraborti
Journal:  Mol Cell Biochem       Date:  2005-02       Impact factor: 3.396

4.  Activation of proMMP-2 by U46619 occurs via involvement of p(38)MAPK-NFκB-MT1MMP signaling pathway in pulmonary artery smooth muscle cells.

Authors:  Animesh Chowdhury; Soumitra Roy; Tapati Chakraborti; Kuntal Dey; Sajal Chakraborti
Journal:  Mol Cell Biochem       Date:  2013-09-25       Impact factor: 3.396

5.  Cross-talk between NADPH oxidase-PKCα-p(38)MAPK and NF-κB-MT1MMP in activating proMMP-2 by ET-1 in pulmonary artery smooth muscle cells.

Authors:  Jaganmay Sarkar; Animesh Chowdhury; Tapati Chakraborti; Sajal Chakraborti
Journal:  Mol Cell Biochem       Date:  2016-02-24       Impact factor: 3.396

6.  Human herpesvirus-8 infection of primary pulmonary microvascular endothelial cells.

Authors:  Todd M Bull; Christina A Meadows; Christopher D Coldren; Mark Moore; Sylk M Sotto-Santiago; Serge P Nana-Sinkam; Thomas B Campbell; Mark W Geraci
Journal:  Am J Respir Cell Mol Biol       Date:  2008-06-27       Impact factor: 6.914

7.  Reversal of experimental pulmonary hypertension by PDGF inhibition.

Authors:  Ralph Theo Schermuly; Eva Dony; Hossein Ardeschir Ghofrani; Soni Pullamsetti; Rajkumar Savai; Markus Roth; Akylbek Sydykov; Ying Ju Lai; Norbert Weissmann; Werner Seeger; Friedrich Grimminger
Journal:  J Clin Invest       Date:  2005-10       Impact factor: 14.808

8.  Perivascular T-cell infiltration leads to sustained pulmonary artery remodeling after endothelial cell damage.

Authors:  Michael J Cuttica; Thomas Langenickel; Audrey Noguchi; Roberto F Machado; Mark T Gladwin; Manfred Boehm
Journal:  Am J Respir Cell Mol Biol       Date:  2010-09-02       Impact factor: 6.914

9.  Quantification of uncertainty in a new network model of pulmonary arterial adventitial fibroblast pro-fibrotic signalling.

Authors:  Ariel Wang; Shulin Cao; Yasser Aboelkassem; Daniela Valdez-Jasso
Journal:  Philos Trans A Math Phys Eng Sci       Date:  2020-05-25       Impact factor: 4.226

10.  Role of the TGF-beta/Alk5 signaling pathway in monocrotaline-induced pulmonary hypertension.

Authors:  Ari L Zaiman; Megan Podowski; Satya Medicherla; Kimberley Gordy; Fang Xu; Lijie Zhen; Larissa A Shimoda; Enid Neptune; Linda Higgins; Alison Murphy; Sarvajit Chakravarty; Andrew Protter; Pravin B Sehgal; Hunter C Champion; Rubin M Tuder
Journal:  Am J Respir Crit Care Med       Date:  2008-01-17       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.